Effect of cytochrome P450-dependent epoxyeicosanoids on Ristocetin-induced thrombocyte aggregation

Clinical Hemorheology and Microcirculation

Volumn 52, Issue 2-4, 2012, Pages 403-416

  Jung, F ^a   Schulz, C ^a   Blaschke, F ^b,d   Muller, D N ^b   Mrowietz, C ^a   Franke, R P ^c   Lendlein, A ^a   Schunck, W H ^b  

^a Institute of Polymer Research   (Germany)

^b MAX DELBRÜCK CENTER FOR MOLECULAR MEDICINE   (Germany)

^c UNIVERSITY OF ULM   (Germany)

^d CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

11,12 POXYEICOSATRIENOIC ACID; 12 (3 ADAMANTAN 1 YL UREIDO)DODECANOIC ACID; 17,18 EPOXYEICOSATETRAENOIC ACID; ADENOSINE DIPHOSPHATE; ANTICOAGULANT AGENT; CYTOCHROME P450; DOCOSAPENTAENOIC ACID; EPOXYDOCOSAPENTAENOIC ACID; EPOXYICOSATRIENOIC ACID; HYDROLASE INHIBITOR; ICOSANOID; ICOSATETRAENOIC ACID; RISTOCETIN; UNCLASSIFIED DRUG;

AMPLITUDE MODULATION; ANTICOAGULATION; ARTICLE; BLOOD VESSEL WALL; CONCENTRATION RESPONSE; CONTROLLED STUDY; DRUG POTENTIATION; HUMAN; HUMAN CELL; HUMAN TISSUE; MALE; NORMAL HUMAN; THROMBOCYTE ADHESION; THROMBOCYTE AGGREGATION INHIBITION; THROMBOCYTE RICH PLASMA; TURBIDIMETRY; VELOCITY;

ANTI-BACTERIAL AGENTS; BLOOD PLATELETS; CELL AGGREGATION; CYTOCHROME P-450 ENZYME SYSTEM; EICOSANOIDS; HUMANS; MALE; OXIDATION-REDUCTION; RISTOCETIN;

EID: 84868611920     PISSN: 13860291     EISSN: 18758622     Source Type: Journal    
DOI: 10.3233/CH-2012-1614     Document Type: Article

References (62)

1. R.K. Andrews, E.E. Gardiner, Y. Shen, J.C. Whisstock and M.C. Berndt, Molecules in focus. Glyoprotein Ib-IX-V. International Journal of Biochemistry & Cell Biology 35 (2003), 1170-1174.
2. Anonymous, Ethical guidelines for publication in Clinical Hemorheology and Microcirculation, Clinical Hemorheology and Microcirculation 44 (2010), 1-2.
3. S.L. Archer, F.S. Gragasin, X. Wu, S. Wang, S. McMurtry, D.H. Kim, M. Platonov, A. Koshal, K. Hashimoto, W.B. Campbell, J.R. Falck and E.D. Michelakis, Endothelium-derived hyperpolarizing factor in human internal mammary artery is 11,12-epoxyeicosatrienoic acid and causes relaxation by activating smooth muscle BK(Ca) channels, Circulation 107 (2003), 769-776. (Pubitemid 36222608)
4. C. Arnold, M. Markovic, K. Blossey, G. Wallukat, R. Fischer, R. Dechend, A. Konkel, C. von Schacky, F.C. Luft, D.N. Muller, M. Rothe and W.H. Schunck, Arachidonic acid-metabolizing cytochrome p450 enzymes are targets of omega-3 fatty acids, J Biol Chem 285 (2010), 32720-31733.
5. O.K. Baskurt, M. Boynard, G.C. Cokelet, P. Connes, B.M. Cooke, S. Forconi, F. Liao, R. Hardeman, F. Jung, H.J. Meiselman, G. Nash, N. Nemeth, B. Neu, B. Sandhagen, S. Shin, G. Thurston and J.L. Wautier, International expert panel for standardization of hemorheological methods. New guidelines for hemorheological laboratory techniques, Clin Hemorheol Microcirc 42 (2009), 75-97.
6. B. Berg, H.E. Solberg, J.E. Nilsson and N. Tryding, Practical experience in the selection and preparation of reference individuals: Empirical testing of the provisional scandinavian recommendations. In: Reference values in laboratory medicine. R. Gräsbeck, T. Alström (eds). John Wiley & sons, Chichester (1981), pp. 55-64.
7. M.C. Berndt and J.P. Caen, Platelet glycoproteins, Prog Haemost Thromb 7 (1984), 111-150.
8. M.C. Berndt, X. Du and W.J. Booth, Ristocetin-dependent reconstitution of von Willebrand factor to purified human platelet membrane glycoprotein IB-IX complex, Biochemistry 1988 (27), 633-640. (Pubitemid 18043508)
9. G.V. Born and M.J. Cross, The Aggregation of blood platelets, J Physiol 168 (1963), 178-195.
10. W.B. Campbell and J.R. Falck, Arachidonic acid metabolites as endothelium-derived hyperpolarizing factors, Hypertension 49 (2007), 590-596.
11. K.J. Clemetson, Platelet activation: Signal transduction via membrane receptors, Thromb Haemostas 74 (1995), 111-116.
12. M.G. Cohen, J.S. Rossi, J. Garbarino, R. Bowling, A.A. Motsinger-Reif, C. Schuler, A.G. Dupont and D. Gabriel, Insights into the inhibition of platelet activation by omega-3 polyunsaturated fatty acids: Beyond aspirin and clopidogrel, Thromb Res 128 (2011), 335-340.
13. B.S. Coller and H.R. Gralnick, Biochemical mechanism of ristocetin-induced platelet agglutination, Clin Res 24 (1976), 305A.
14. B. Fisslthaler, R. Popp, L. Kiss, M. Potente, D.R. Harder, I. Fleming and R. Busse, Cytochrome P450 2C is an EDHF synthase in coronary arteries, Nature 401 (1999), 493-497. (Pubitemid 29470209)
15. F.A. Fitzpatrick, M.D. Ennis, M.E. Baze, M.A. Wynalda, J.E. McGee and W.F. Liggett, Inhibition of cyclooxygenase activity and platelet aggregation by epoxyeicosatrienoic acids, J Biol Chem 261 (1986), 15334-15338. (Pubitemid 17218115)
16. I. Fleming, Cytochrome p450 and vascular homeostasis, Circ Res 89 (2001), 753-762.
17. I. Fleming, Epoxyeicosatrienoic acids, cell signaling and angiogenesis, Prostaglandins Other Lipid Mediat 82 (2007), 60-67. (Pubitemid 44880162)
18. Fourth. American College of Chest Physicians Consensus Conference on Antithrombotic Therapy, Chest 108(4 Suppl) (1995), 225S-522S.
19. L.T. Friedhoff, E. Kim, M. Priddle and M. Sonenberg, The effect of altered transmembrane ion gradients on membrane potential and aggregation of human platelets in blood plasma, Biochem Biophys Res Commun 102 (1981), 832-837. (Pubitemid 12213806)
20. B. Furie and B.C. Furie, Role of platelet P-selectin and microparticle PSGL-1 in thrombus formation, Trends mol med 10 (2004), 171-178. (Pubitemid 38410975)
21. G. Gajos, P. Rostoff, A. Undas and W. Piwowarska, Effects of polyunsaturated omega-3 fatty acids on responsiveness to dual antiplatelet therapy in patients undergoing percutaneous coronary intervention: The omega-pci (omega-3 fatty acids after pci to modify responsiveness to dual antiplatelet therapy) study, J Am Coll Cardiol 55 (2010), 1671-1678.
22. D. Green and E.V. Potter, Platelet-bound ristocetin aggregation factor in normal subjects and patients with vonWillebrand's disease, J Lab Clin Med 87 (1976), 976-986.
23. M.L. Heizer, J.S. McKinney and E.F. Ellis, 14,15-Epoxyeicosatrienoic acid inhibits platelet aggregation in mouse cerebral arterioles, Stroke 22 (1991), 1389-1393.
24. H.C. Hercule, B. Salanova, K. Essin, H. Honeck, J.R. Falck, M. Sausbier, P. Ruth, W.H. Schunck, F.C. Luft and M. Gollasch, The vasodilator 17,18-epoxyeicosatetraenoic acid targets the pore-forming bk alpha channel subunit in rodents, Exp Physiol 92 (2007), 1067-1076. (Pubitemid 47568840)
25. L.J. Ignarro, Biological actions and properties of endothelium-derived nitric oxide formed and released from artery and vein, Circ Res 65 (1989), 1-21.
26. M. Joner, A.V. Finn, A. Farb, E.K. Mont, F.D. Kolodgie, E. Ladich, R. Kutys, K. Skorija, H.K. Gold and R. Virmani, Pathology of rertug-eluting stents in humans: Delayed heaöling and late thrombotic risk, J Am Coll Cardiol 48 (2006), 193-202. (Pubitemid 43929240)
27. F. Jung, C. Mrowietz, U.T. Seyfert, R. Grewe and R.P. Franke, Influence of the direct NO-donor SIN-1 on the interaction between platelets and stainless steel stents under dynamic conditions, Clin Hemorheol Microcirc 28 (2003), 189- 199. (Pubitemid 36995066)
28. F. Jung, C. Wischke and A. Lendlein, Degradable, multifunctional cardiovascular implants: Challenges and hurdles, MRS Bull 35 (2010), 607-613.
29. H.E. Kattlove and M.H. Gomez, Studies on the mechanism of ristocetin-induced platelet aggregation, Blood 45 (1975), 91-96.
30. C. Kenneth, C. Malcolm and F.A. Fitzpatrick, Epoxyeicosatrienoic acids inhibit Ca2+ entry into platelets stimulated by thapsigargin and thrombin, J Biol Chem 267 (1992), 19854-13858.
31. I.H. Kim, K. Nishi, H.J. Tsai, T. Bradford, Y. Koda, T. Watanabe, C. Morisseau, J. Blanchfield, I. Toth and B.D. Hammock, Design of bioavailable derivatives of 12-(3-adamantan-1-yl-ureido)dodecanoic acid, a potent inhibitor of the soluble epoxide hydrolase, Bioorg Med Chem 15 (2007), 312-323. (Pubitemid 44738574)
32. A. Konkel and W.H. Schunck, Role of cytochrome P450 enzymes in the bioactivation of polyunsaturated fatty acids, Biochim Biophys Acta 1814 (2011), 210-222.
33. F. Krötz, T. Riexinger, M.A. Buerkle, K. Nithipatikom, T. Gloe, H.Y. Sohn, W.B. Campbell and U. Pohl, Membrane potential-dependent inhibition of platelet adhesion to endothelial cells by epoxyeicosatrienoic acids, Arterioscler Thromb Vasc Biol 24 (2004), 595-600. (Pubitemid 38326158)
34. F. Krötz, N. Hellwig, M.A.Bürkle, S. Lehrer, T. Riexinger,H. Mannell, H.Y. Sohn,V. Klauss and U. Pohl,Asulfaphenazolesensitive EDHF opposes platelet-endothelium interactions in vitro and in the hamster microcirculation in vivo, Cardiovasc Res 85 (2010), 542-550.
35. B. Lauterbach, E. Barbosa-Sicard, M.H.Wang, H. Honeck, E. Kärgel, J. Theuer, M.L. Schwartzman, H. Haller, F.C. Luft, M. Gollasch and M.H. Schunck, Cytochrome P450-dependent eicosapentaenoic acid metabolites are novel BK channel activators, Hypertension 39 (2002), 609-613. (Pubitemid 34165192)
36. T. Lhermusier, H. Chap and B. Payrastre, Platelet membrane phospholipid asymmetry: From the characterization of a scramblase activity to the identification of an essential protein mutated in Scott syndrome, J Thromb Haemost 9 (2011), 1883-1891.
37. O.J.T. McMarty, S.D.J. Calaminus, M.C. Berndt, L.M. Machesky and S.P. Watson, Von Willebrand factor mediates platelet spreading through glycoprotein IB and GPIIbIIIa in the presence of botrocetin and ristocetin, respectively, Thromb Haemostas 4 (2006), 1367-1378.
38. E.P. Milner, Q. Zheng and J.C. Kermode, Ristocetin-mediated interaction of human von Willerand factor with platelet glycoprotein Ib evokes a transient calcium signal: Observations with FURA-PE3, J Lab Clin Med 131 (1998), 49-62. (Pubitemid 28065768)
39. H. Miura and D.D. Gutterman, Human coronary arteriolar dilation to arachidonic acid depends on cytochrome P-450 monooxygenase and Ca2+-activated K+channels, Circ Res 83 (1998), 501-507. (Pubitemid 28411051)
40. E. Morgenstern, A. Ruf and H. Patscheke, Ultrastructure of the interaction between human platelets and polymerizing fibrin within the first minutes of clot formation, Blood Coagul Fibrinolysis 1 (1990), 543-546.
41. G. Nakazawa, A.V. Finn, M.C. John, F.D.Kolodgie and R.Virmani, The significance of preclinical evaluation of sirolimus-, paclitaxel- and zotarolimus-slitung stents, Am J Cardiol 100 (2007), 36-44.
42. E. Pipili, Platelet membrane potential: Simultaneous measurement of diSC3(5) fluorescence and optical density, Thromb Haemostas 54 (1985), 645-649. (Pubitemid 16195310)
43. J. Quilley and J.C. McGiff, Is EDHF an epoxyeicosatrienoic acid? Trends Pharmacol Sci 21 (2000), 121-124. (Pubitemid 30190132)
44. T. Riexinger, Ein Cytochrom P450 2C8/9-abhängig gebildeter EDHF hyperpolarisiert Thrombozyten und hemmt deren Adhäsion an Endothelzellen. Dissertationsschrift, Ludwig-Maximilians-Universität, München, 2008.
45. G.E. Revtyak, M.J. Hughes, A.R. Johnson andW.B. Campbell, Histamine stimulation of prostaglandin and HETE synthesis in human endothelial cells, Am J Physiol 255 (1988), C214-C225.
46. R.J. Roman, P-450 metabolites of arachidonic acid in the control of cardiovascular function, Physiol Rev 82 (2002), 131-185. (Pubitemid 34654217)
47. D. Sacerdoti, C. Colombrita, M. Di Pascoli, M.L. Schwartzman, M. Bolognesi, J.R. Falck, A. Gatta and N.G. Abraham, 11,12-epoxyeicosatrienoic acid stimulates heme-oxygenase-1 in endothelial cells, Prostaglandins Other Lipid Mediat 82 (2007), 155-161. (Pubitemid 44880175)
48. G.V.F. Seaman and D.E. Brooks, Electrochemical aspects of platelet adhesion and aggregation, Thromb Diath Haemorrh 42 (1970), 93-107.
49. A.A. Spector and A.W. Norris, Action of epoxyeicosatrienoic acids on cellular function, Am J Physiol Cell Physiol 292 (2007), C996-1012.
50. V. Sudhahar, S. Shaw and J.D. Imig, Epoxyeicosatrienoic acid analogs and vascular function, Curr Med Chem 17 (2010), 1181-1190.
51. N.J. Truss and T.D. Warner, Gasotransmitters and platelets, Pharmacol Ther 132 (2011), 196-203.
52. V.T. Turitto, H.J. Weiss, T.S. Zimmerman and I.I. Sussman, FactorVIII/vonWillebrand factor in subendothelium mediates platelet adhesion, Blood 65 (1985), 823-831. (Pubitemid 15115507)
53. B. van der Loo, S. Spring and R. Koppensteiner, High-dose atorvastatin tratment in patients with peripheral arterial disease: Effects on platelet aggregation, blood rheology and plasma homocysteine, Clin Hemorheol Microcir 47 (2011), 241-251.
54. M. VanRollins, Epoxygenase metabolites of docosahexaenoic and eicosapentaenoic acids inhibit platelet aggregation at concentrations below those affecting thromboxane synthesis, J Pharmacol Exp Ther 274 (1995), 798-804.
55. R.X. Wang, Q. Chai, T. Lu and H.C. Lee, Activation of vascular BK channels by docosahexaenoic acid is dependent on cytochrome P450 epoxygenase activity, Cardiovas Res 90 (2011), 344-352.
56. M.D. Widmann, N.L. Weintraub, J.L. Fudge, L.A. Brooks and K.C. Dellsperger, Cytochrome P-450 pathway in acetylcholine-induced canine coronary microvascular vasodilation in vivo, Am J Physiol 274 (1998), H283-H289.
57. D. Ye, D. Zhang, C. Oltman, K. Dellsperger, H.C. Lee and M. VanRollins, Cytochrome p-450 epoxygenase metabolites of docosahexaenoate potently dilate coronary arterioles by activating large-conductance calcium-activated potassium channels, J Pharmacol Exp Ther 303 (2002), 768-776. (Pubitemid 35231254)
58. D.C. Zeldin, J. Kobayashi, J.R. Falck, B.S. Winder, B.D. Hammock, J.R. Snapper and J.H. Capdevila, Regio-, and enantiofacial selectivity of epoxyeicosatrienoic acid hydration by cytosolic epoxide hydrolase, J Biol Chem 268 (1993), 6402-6407. (Pubitemid 23099336)
59. L. Zhang, Y. Cui, B. Geng, X. Zeng and C. Tang, 11,12-Epoxyeicosatrienoic acid activates the L-arginine/nitric oxide pathway in human platelets, Mol Cell Biochem 308 (2008), 51-56. (Pubitemid 351167844)
60. Y. Zhang, C.L. Oltman, T. Lu, H.C. Lee, K.C. Dellsperger and M. VanRollins, EET homologs potently dilate coronary microvessels and activate bk(ca) channels, Am J Physiol Heart Circ Physiol 280 (2001), H2430-H2440.
61. Y. Zhu, E.B. Schieber, J.C. McGiff and M. Balazy, Identification of arachidonate P-450 metabolites in human platelet phospholipids, Hypertension 25 (1995), 854-859.
62. M. Zucker, K. Sook-Ja, J. McPherson and R. Grant, A. Binding of factor VIII to platelets in the presence of ristocetin, Br J Haematol 35 (1977), 535-549. (Pubitemid 8091160)